{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-014775","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.314577+00:00","generated_at":"2026-06-24T04:28:24.404107+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q2 revenue up 34% to $670M, adjusted EBITDA turns positive at $7M","bullets":["Revenue $670M (+34% YoY); normalized growth 42% excluding prior-year retroactive contract.","Net loss narrowed to $21M from $299M loss in Q2 2021 which included $275M non-cash stock comp.","Medical margin $82M (+49% YoY), 12.2% of revenue vs 11.1% a year ago.","Total members on platform 351,700; MA membership up 44% YoY, same-geography growth 13%.","FY 2022 guidance: revenue $2.615-2.635B, adjusted EBITDA $0-10M, total members 345-355K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-014775","json":"https://secwatch.observer/filing/0000950170-22-014775.json","markdown":"https://secwatch.observer/filing/0000950170-22-014775.md","text":"https://secwatch.observer/filing/0000950170-22-014775.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/0000950170-22-014775-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/agl-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:28:24.404107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}